Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-11-10, Stock:ABBV, The news for the past five days is as follows:
2021-11-03: NEWS1: Vertex Stock Is Climbing After Strong Earnings, but the Competition Hasn’t Gone Away..NEWS2: 10 High-Yield Monthly Dividend Stocks to Buy in November.NEWS3: 10 Dividend Stocks to Buy According to Nicholas Bagnall’s Te Ahumairangi Investment Management.
2021-11-04: NEWS1: AbbVie to Highlight New Advances in Blood Cancer Research and Expanding Oncology Pipeline at 63rd ASH Annual Meeting.
2021-11-05: NEWS1: Top Analyst Reports for Tesla, Comcast & AbbVie.NEWS2: Ironwood (IRWD) Q3 Earnings Top, Sales Hurt by Lower Price.NEWS3: AbbVie Presents Integrated Efficacy and Safety Data From Two Phase 3 Trials on Risankizumab (SKYRIZI®) in Psoriatic Arthritis at ACR Convergence 2021.NEWS4: Testing May Take Awhile, but Gene Therapy Is Poised to Tackle Mass Diseases.
2021-11-08: NEWS1: Allergan, an AbbVie Company, to Present New Data from its Leading Eye Care Portfolio at the AAO (American Academy of Ophthalmology) 2021 Annual Meeting.NEWS2: The Zacks Analyst Blog Highlights: Tesla, Comcast, AbbVie, Boeing, China Petroleum & Chemical and Advanced Micro Devices.NEWS3: 3 Best Biotech Stocks to Buy in November.
2021-11-09: NEWS1: AbbVie Presents New Efficacy Data on Upadacitinib (RINVOQ®) in People with Active Psoriatic Arthritis and Axial Involvement at ACR Convergence 2021.NEWS2: AbbVie to Present New Long-term Analysis Evaluating the Sustainability of Response to RINVOQ® (Upadacitinib) Among Patients with Rheumatoid Arthritis.

Answer: Rise